Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-02-23 @ 9:21 PM
Study NCT ID:
NCT01808950
Status:
TERMINATED
Last Update Posted:
2016-06-22
First Post:
2013-03-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma
Sponsor:
Spirig Pharma Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SP848-nBCC-1104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None